Director of Malignant Hematology Program

The Director of the Malignant Hematology Program will be responsible for providing strategic direction and leadership across our comprehensive portfolio of hematologic malignancy programs. The successful candidate will oversee clinical operations for 13 disease-focused subspecialty programs, ensure excellence in multidisciplinary patient care, and spearhead research initiatives that advance the field of malignant hematology. This role presents an exceptional opportunity to build upon our robust clinical and research infrastructure, collaborating with faculty and university leaders to support our integrated academic, research, and clinical missions.

Requirements include :

1.  MD, DO, or equivalent degree with BC in Hem / Onc, with demonstrated expertise across multiple hematologic malignancies.

2.  5+ years of experience leading clinical, translational, and / or basic research programs in malignant hematology, along with an independent, extramurally funded research program (e.g., NIH R01, cooperative group leadership, or industry-sponsored investigational studies).

3.  Demonstrate substantial academic productivity with 5+ years of peer-reviewed publications in hematologic malignancies, along with evidence of successful grant acquisition and research program leadership across multiple disease areas.

4.  Mid to senior-level faculty experience required, with demonstrated leadership capabilities in academic medicine and program development.

Responsibilities

• Lead and manage the comprehensive Malignant Hematology Program encompassing 13 disease-focused subspecialty areas across Indiana University Health's academic medical centers
• Collaborate closely with the Hematopoiesis and Hematological Malignancies (HHM) Research Program at IUSCCC to advance translational research initiatives
• Work in strategic partnership with the Brown Center for Immunotherapy at Indiana University Melvin and Bren Simon Comprehensive Cancer Center to integrate novel cellular therapy approaches for treatment
• Develop and implement strategic initiatives to enhance patient outcomes, expand clinical trial portfolios, and establish disease-specific programs as regional and national referral centers
• Provide clinical oversight and academic guidance to multidisciplinary teams, subspecialty faculty, fellows, residents, and advanced practice providers while mentoring junior faculty
• Expand the research portfolio with emphasis on investigator-initiated clinical trials, cooperative group studies, and translational research spanning the spectrum of hematologic malignancies
• Serve as liaison with external partners, pharmaceutical industry, cooperative groups, and national cancer networks to develop collaborative research opportunities and enhance the program's national prominence
• Foster interdisciplinary collaboration among the 13 disease-focused programs to promote knowledge sharing and optimize patient care delivery

Practice Structure

Indianapolis, Indiana , the 17th largest U.S. city, is a sophisticated city blending charm and culture with a wonderful balance of business and leisure.  Residents of this dynamic city enjoy :